LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

LGC Clinical Diagnostics Demonstrates How Labs Can Enhance QC Efficiencies at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 06 Feb 2023
Image: Multichem is a class leading, third-party, test-consolidated QC product range (Photo courtesy of LGC)
Image: Multichem is a class leading, third-party, test-consolidated QC product range (Photo courtesy of LGC)

LGC Clinical Diagnostics (Middlesex, UK) is attending Medlab Middle East 2023 where it is demonstrating how laboratories can enhance their quality control (QC) efficiencies through automated processes with independent QC and QC data management.

Under LGC Clinical Diagnostics Group, the company’s booth at this year’s Medlab Middle East is representing the combined brands: Maine Standards, SeraCare, Technopath Clinical Diagnostics, and The Native Antigen Company. LGC is presenting its comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions and component materials with representatives from each company available to answer all the questions of visitors at its booth.

At Medlab Middle East 2023, LGC is showcasing Technopath’s total QC solution, Multichem QC and IAMQC software that provide clinical laboratories with significant cost, handling and time savings, whilst delivering higher confidence in analytical testing methods. With an extensive list of analytes included in the Multichem range of QC products, choice and flexibility are guaranteed for all customers. The third party QC products include General Clinical Chemistry, Immunoproteins, Immunoassay, Cardiac, Urine Chemistry, Infectious Disease, Diabetes and other Esoteric controls. The controls are offered in assayed and unassayed formats. Technopath’s human based control matrix offers unrivalled test consolidation through increased control stability and diminished matrix effects. Together, these aspects of control manufacture offer greater control efficiencies without compromising compliance or confidence in patient results.

LGC is also demonstrating the IAMQC Software from Technopath that provides laboratory managers and technologists with a range of QC software tools to analyze their QC results in real-time. IAMQC Software tools allow users to automate, centralize, standardize and improve QC processes in a laboratory setting. A combination of modules satisfies the varying levels of QC requirements in individual laboratories and is easily tailored to meet different QC management expectations. This also includes the new IAMQC Infinity that incorporates all the functionality of IAMQC Peer, Daily and Expert in one application. The powerful cloud based software designed to exactly meet specific QC solution needs has a feature-based interface that allows the laboratory to build their custom solution and then to seamlessly add in further sophisticated features as and when needed.

Related Links:
LGC

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more